ClinicalTrials.Veeva

Menu

Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Symptomatic Irreversible Pulpitis

Treatments

Procedure: Biodentine Pulpotomy
Procedure: MTA Pulpotomy.

Study type

Interventional

Funder types

Other

Identifiers

NCT03890835
CEBD-CU-2019-03-10

Details and patient eligibility

About

The aim of this study is to compare treatment outcomes of pulpotomy in mature permanent teeth using Biodentine versus MTA regarding postoperative pain and success rate.

Full description

Patients will be clinically and radiographically examined and their eligibility will be assessed. Eligible patients will be randomly assigned to one of 2 groups: experimental group (pulpotomy using Biodentine) and the control group (pulpotomy using MTA). After adminsrtation of local anesthesia, pulpotomy will be done under rubber dam isolation. The pulp tissue will be removed until the level of the orifices of the canals. After hemostasis is achieved, the capping material will be placed. In the experimental group, the capping material is Biodentine while in the control group, the capping material is MTA The cavities will be sealed with resin-modified glass ionomer. Then the teeth will be permanently restored with composite . A post-operative radiograph will be taken. The patients will be given a pain diary based on Numerical Rating Scale (NRS) and asked to rate their pain level at the specified times. The patients will be recalled after 6 and 12 months post-operatively.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aging between 18-40 years old
  • Patients with symptomatic irreversible pulpitis.
  • Radiographically: Absence or slight widening in periodontal ligament space.
  • Systemically- healthy patients (ASA I or II).
  • Patients who agree to attend for recall appointments and provide written consent.

Exclusion criteria

  • Severe marginal periodontitis.
  • Necrotic pulp, pulp polyp, tooth tender to percussion, clinical progression into periapical abscess, fistula.
  • Non-restorable teeth, teeth with internal/external root resorption or root canal calcification.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

70 participants in 2 patient groups

Mineral Trioxide Aggregate (MTA)
Active Comparator group
Treatment:
Procedure: MTA Pulpotomy.
Biodentine
Experimental group
Treatment:
Procedure: Biodentine Pulpotomy

Trial contacts and locations

0

Loading...

Central trial contact

Suzan AW Amin, Ph.D.; Youssef A. Kamal Elalfy, B.D.S

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems